BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Sartorius Stedim Biotech Partners with Nanotein to Advance Immune Cell Manufacturing with NanoSpark® Reagents

Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for...

August 11, 2025 | News

RemeGen Secures FDA Clearance for Phase II Trials of Innovative Bispecific Antibody RC148 in Advanced Solid Tumors

RemeGen Co., announces clearance of IND application by Food and Drug Administration (FDA) for phase II clinical trials for its independently-developed bisp...

August 11, 2025 | News

Astria Licenses HAE Drug Navenibart to Japan’s Kaken in $32M+ Deal

-- Up to $32 Million in Upfront and Milestone Payments, Plus Royalties -- -- Kaken Expertise in Commercializing Innovative Therapies Supports Navenibart...

August 08, 2025 | News

“Spatial Biology at Scale: 10x Genomics CEO Serge Saxonov on Redefining Precision Medicine with TISHUMAP”

The future of medicine is being shaped at the intersection of spatial biology and artificial intelligence—and 10x Genomics is l...

August 07, 2025 | Interaction

SOPHiA GENETICS and AstraZeneca Expand AI Collaboration to Advance Personalised Breast Cancer Care

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine,announced an expansion of its...

August 06, 2025 | News

Precision Therapies Set to Unlock USD 1.6 Trillion in Economic Impact Across Asia-Pacific

As Asia-Pacific bears nearly half of the global cancer burden, precision medicine is emerging not only as a clinical breakthrough but also as a powerful ec...

August 04, 2025 | Interview

GenScript Biotech Earns MSCI AA ESG Rating, Recognised as Global Sustainability Leader

GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG rating...

August 04, 2025 | News

Everest Medicines Invests US$30.9 Million in I-Mab to Advance Next-Gen Immuno-Oncology Therapies

- Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash in I-Mab. Inclusive of I-MAB shares alread...

August 04, 2025 | News

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...

August 04, 2025 | News

Quanterix Launches First-to-Market p‑Tau 205 and 212 Assays, Expanding Alzheimer’s Biomarker Portfolio

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, announced the first to market, com...

August 01, 2025 | News

Thermo Fisher Introduces MagMAX™ HMW DNA Kit to Streamline Long-Read Sequencing Workflows

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ HMW DNA Kit, providing a streamlined manual and automated extraction wo...

August 01, 2025 | News

Agilent Technologies Unveils Biopharma Experience Centre in Hyderabad to Accelerate India’s Life Sciences Innovation

Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, announced the inauguration of its state-of-the-art...

August 01, 2025 | News

Asahi Kasei to Build New Planova™ Virus Filter Plant in Japan to Meet Surging Biopharma Demand

Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova&trad...

July 31, 2025 | News

South Korea’s DXVX Inks $220M Global Out-Licensing Deal for mRNA Cancer Vaccine with U.S. Biotech

Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-developmen...

July 31, 2025 | News

Stay Connected